Prevail Therapeutics Inc. has reached its limit for free report views

Work for Prevail Therapeutics Inc.? Upgrade Your Profile and unlock all your annual reports.

Upgrade Profile

Prevail Therapeutics Inc.

Ticker PRVL

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

1-10 Employees
Based in New York City, New York

Prevail is a gene therapy company leveraging breakthroughs in human genetics with the goal of developing and commercializing disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases. The Company is developing PR001 for patients with Parkinson’s disease with GBA1 mutations (PD-GBA) and neuronopathic Gaucher disease; PR006 for patients with frontotemporal dementia…More

Visit website

REPORT RATINGS

4.8 / 5.0 (150)

Prevail Therapeutics Inc. reports have an aggregate usefulness score of 4.8 based on 150 reviews.

Prevail Therapeutics Inc.

Most Recent Annual Report

MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Prevail Therapeutics Inc. has reached its limit for free report views.